Advertisement
Screener

CLEAR SECURE, INC. (YOU) Spending and interest coverage

CLEAR SECURE, INC. (YOU) Spending and interest coverage

  • R&D / revenue · 12 months: Value 7.23%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 4.32%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months7.23%Research and development expense / revenue. Period ending 2026-06-30.

$72.38M ÷ $1.00B × 100 ≈ 7.23%

Stock-based compensation / revenue · 12 months4.32%Share-based compensation / revenue. Period ending 2026-06-30.

$43.24M ÷ $1.00B × 100 ≈ 4.32%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending72.38M USDResearch and Development Expense
Revenue1.00B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation43.24M USDShare-based Payment Arrangement, Noncash Expense
Operating income251.47M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$72.38M$1.00B$43.24M$251.47M(m)7.23%4.32%(m)(m)
2026-03-31$72.83M$942.41M$42.45M$211.07M(m)7.73%4.50%(m)(m)
2025-12-31$72.38M$900.78M$38.93M$186.48M(m)8.04%4.32%(m)(m)
2025-09-30$73.64M$866.30M$35.98M$166.65M(m)8.50%4.15%(m)(m)
2025-06-30$73.06M$835.53M$32.53M$149.13M(m)8.74%3.89%(m)(m)
2025-03-31$72.25M$802.81M$32.47M$136.91M(m)9.00%4.04%(m)(m)
2024-12-31$73.35M$770.49M$35.34M$123.19M(m)9.52%4.59%(m)(m)
2024-09-30$73.34M$735.18M$29.23M$104.81M(m)9.98%3.98%(m)(m)
2024-06-30$67.70M$697.15M$27.25M$89.00M(m)9.71%3.91%(m)(m)
2024-03-31$72.60M$660.27M$31.31M$58.88M(m)11.00%4.74%(m)(m)
2023-12-31$74.44M$613.58M$37.29M$20.14M(m)12.13%6.08%(m)(m)
2023-09-30$76.49M$570.87M$75.11M$-27.57M(m)13.40%13.16%(m)(m)
2023-06-30$81.21M$526.40M$144.00M$-112.55M(m)15.43%27.35%(m)(m)
2023-03-31$73.23M$479.25M$142.01M$-125.89M(m)15.28%29.63%(m)(m)
2022-12-31$66.80M$437.43M$138.50M$-129.06M(m)15.27%31.66%(m)(m)
2022-09-30$60.55M$389.84M$114.36M$-128.59M(m)15.53%29.33%(m)(m)
2022-06-30$57.39M$341.48M$55.44M$-95.49M(m)16.81%16.24%(m)(m)
2022-03-31$54.00M$293.93M$49.03M$-120.11M(m)18.37%16.68%(m)(m)
2021-12-31$47.49M$253.95M$36.51M$-114.93M(m)18.70%14.38%(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$32.04M$230.80M$3.43M$-18.93M(m)13.88%1.48%(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$21.22M$192.28M$14.66M$-56.16M(m)11.04%7.63%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.